Return On Equity in % of NEVRO CORP from Q2 2015 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NEVRO CORP quarterly/annual Return On Equity history and change rate from Q2 2015 to Q4 2024.
  • NEVRO CORP Return On Equity for the quarter ending 31 Dec 2024 was -42.9 %, a 36.7% decline year-over-year.
  • NEVRO CORP annual Return On Equity for 2024 was -42.9 %, a 36.7% decline from 2023.
  • NEVRO CORP annual Return On Equity for 2023 was -31.4 %, a 3027% decline from 2022.
  • NEVRO CORP annual Return On Equity for 2022 was 1.07 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

NEVRO CORP Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2024 -42.9 -11.5 -36.7% 01 Oct 2024 31 Dec 2024
Q3 2024 -24.8 +9.22 +27.1% 01 Jul 2024 30 Sep 2024
Q2 2024 -27.4 -28.2 -3424% 01 Apr 2024 30 Jun 2024
Q1 2024 -28.7 -29.5 -3782% 01 Jan 2024 31 Mar 2024
Q4 2023 -31.4 -32.5 -3027% 01 Oct 2023 31 Dec 2023
Q3 2023 -34 -31.1 -1076% 01 Jul 2023 30 Sep 2023
Q2 2023 0.82 +51.9 01 Apr 2023 30 Jun 2023
Q1 2023 0.78 +45.4 01 Jan 2023 31 Mar 2023
Q4 2022 1.07 +40.1 01 Oct 2022 31 Dec 2022
Q3 2022 -2.89 +27.4 +90.4% 01 Jul 2022 30 Sep 2022
Q2 2022 -51.1 -32.8 -179% 01 Apr 2022 30 Jun 2022
Q1 2022 -44.6 -21.3 -91.6% 01 Jan 2022 31 Mar 2022
Q4 2021 -39 -14.5 -59.4% 01 Oct 2021 31 Dec 2021
Q3 2021 -30.3 -0.01 -0.03% 01 Jul 2021 30 Sep 2021
Q2 2021 -18.3 +20.6 +52.9% 01 Apr 2021 30 Jun 2021
Q1 2021 -23.3 +17.4 +42.8% 01 Jan 2021 31 Mar 2021
Q4 2020 -24.5 +25.5 +51% 01 Oct 2020 31 Dec 2020
Q3 2020 -30.3 +16.1 +34.7% 01 Jul 2020 30 Sep 2020
Q2 2020 -38.9 +2.21 +5.38% 01 Apr 2020 30 Jun 2020
Q1 2020 -40.7 -8.83 -27.7% 01 Jan 2020 31 Mar 2020
Q4 2019 -50 -29.8 -148% 01 Oct 2019 31 Dec 2019
Q3 2019 -46.3 -28.5 -159% 01 Jul 2019 30 Sep 2019
Q2 2019 -41.1 -25.2 -159% 01 Apr 2019 30 Jun 2019
Q1 2019 -31.8 -15.5 -95% 01 Jan 2019 31 Mar 2019
Q4 2018 -20.1 -5.11 -34% 01 Oct 2018 31 Dec 2018
Q3 2018 -17.9 -0.62 -3.59% 01 Jul 2018 30 Sep 2018
Q2 2018 -15.8 +0.41 +2.52% 01 Apr 2018 30 Jun 2018
Q1 2018 -16.3 -1.31 -8.73% 01 Jan 2018 31 Mar 2018
Q4 2017 -15 -1.93 -14.8% 01 Oct 2017 31 Dec 2017
Q3 2017 -17.3 -2.17 -14.4% 01 Jul 2017 30 Sep 2017
Q2 2017 -16.3 +5.42 +25% 01 Apr 2017 30 Jun 2017
Q1 2017 -15 +10.9 +42% 01 Jan 2017 31 Mar 2017
Q4 2016 -13.1 +16.9 +56.4% 01 Oct 2016 31 Dec 2016
Q3 2016 -15.1 +14.3 +48.7% 01 Jul 2016 30 Sep 2016
Q2 2016 -21.7 +19.4 +47.2% 01 Apr 2016 30 Jun 2016
Q1 2016 -25.9 01 Jan 2016 31 Mar 2016
Q4 2015 -30 01 Oct 2015 31 Dec 2015
Q3 2015 -29.4 01 Jul 2015 30 Sep 2015
Q2 2015 -41.1 01 Apr 2015 30 Jun 2015

NEVRO CORP Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -42.9 -11.5 -36.7% 01 Jan 2024 31 Dec 2024
2023 -31.4 -32.5 -3027% 01 Jan 2023 31 Dec 2023
2022 1.07 +40.1 01 Jan 2022 31 Dec 2022
2021 -39 -14.5 -59.4% 01 Jan 2021 31 Dec 2021
2020 -24.5 +25.5 +51% 01 Jan 2020 31 Dec 2020
2019 -50 -29.8 -148% 01 Jan 2019 31 Dec 2019
2018 -20.1 -5.11 -34% 01 Jan 2018 31 Dec 2018
2017 -15 -1.93 -14.8% 01 Jan 2017 31 Dec 2017
2016 -13.1 +16.9 +56.4% 01 Jan 2016 31 Dec 2016
2015 -30 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.